vs

Side-by-side financial comparison of Aterian, Inc. (ATER) and Cytosorbents Corp (CTSO). Click either name above to swap in a different company.

Aterian, Inc. is the larger business by last-quarter revenue ($15.1M vs $9.2M, roughly 1.6× Cytosorbents Corp). Aterian, Inc. runs the higher net margin — -52.5% vs -59.5%, a 7.0% gap on every dollar of revenue. On growth, Cytosorbents Corp posted the faster year-over-year revenue change (0.9% vs -38.5%). Aterian, Inc. produced more free cash flow last quarter ($-1.0M vs $-4.9M). Over the past eight quarters, Cytosorbents Corp's revenue compounded faster (1.3% CAGR vs -13.5%).

Aterian, Inc. is a technology-enabled consumer products company that leverages artificial intelligence and data analytics to identify market demand, develop, source and distribute a wide portfolio of affordable goods spanning home improvement, wellness, personal care, pet supplies and outdoor recreation. It primarily sells its products through leading global e-commerce platforms, with core markets covering North America and Europe.

CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.

ATER vs CTSO — Head-to-Head

Bigger by revenue
ATER
ATER
1.6× larger
ATER
$15.1M
$9.2M
CTSO
Growing faster (revenue YoY)
CTSO
CTSO
+39.4% gap
CTSO
0.9%
-38.5%
ATER
Higher net margin
ATER
ATER
7.0% more per $
ATER
-52.5%
-59.5%
CTSO
More free cash flow
ATER
ATER
$3.9M more FCF
ATER
$-1.0M
$-4.9M
CTSO
Faster 2-yr revenue CAGR
CTSO
CTSO
Annualised
CTSO
1.3%
-13.5%
ATER

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ATER
ATER
CTSO
CTSO
Revenue
$15.1M
$9.2M
Net Profit
$-7.9M
$-5.5M
Gross Margin
56.1%
73.7%
Operating Margin
-51.1%
-47.5%
Net Margin
-52.5%
-59.5%
Revenue YoY
-38.5%
0.9%
Net Profit YoY
-512.2%
27.4%
EPS (diluted)
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATER
ATER
CTSO
CTSO
Q4 25
$15.1M
$9.2M
Q3 25
$19.0M
$9.5M
Q2 25
$19.5M
$9.6M
Q1 25
$15.4M
$8.7M
Q4 24
$24.6M
$9.2M
Q3 24
$26.2M
$8.6M
Q2 24
$28.0M
$8.8M
Q1 24
$20.2M
$9.0M
Net Profit
ATER
ATER
CTSO
CTSO
Q4 25
$-7.9M
$-5.5M
Q3 25
$-2.3M
$-3.2M
Q2 25
$-4.9M
$1.9M
Q1 25
$-3.9M
$-1.5M
Q4 24
$-1.3M
$-7.6M
Q3 24
$-1.8M
$-2.8M
Q2 24
$-3.6M
$-4.3M
Q1 24
$-5.2M
$-6.1M
Gross Margin
ATER
ATER
CTSO
CTSO
Q4 25
56.1%
73.7%
Q3 25
56.1%
70.3%
Q2 25
54.3%
70.9%
Q1 25
61.4%
71.1%
Q4 24
63.4%
68.4%
Q3 24
60.3%
61.0%
Q2 24
60.4%
73.5%
Q1 24
65.1%
76.5%
Operating Margin
ATER
ATER
CTSO
CTSO
Q4 25
-51.1%
-47.5%
Q3 25
-10.7%
-30.2%
Q2 25
-23.1%
-37.6%
Q1 25
-24.1%
-44.5%
Q4 24
-6.5%
-37.1%
Q3 24
-6.6%
-56.1%
Q2 24
-11.5%
-40.4%
Q1 24
-26.1%
-51.8%
Net Margin
ATER
ATER
CTSO
CTSO
Q4 25
-52.5%
-59.5%
Q3 25
-12.0%
-33.4%
Q2 25
-25.0%
20.2%
Q1 25
-25.4%
-16.9%
Q4 24
-5.3%
-82.7%
Q3 24
-6.8%
-32.1%
Q2 24
-13.0%
-48.6%
Q1 24
-25.5%
-67.7%
EPS (diluted)
ATER
ATER
CTSO
CTSO
Q4 25
$-0.09
Q3 25
$-0.05
Q2 25
$0.03
Q1 25
$-0.02
Q4 24
$-0.14
Q3 24
$-0.05
Q2 24
$-0.08
Q1 24
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATER
ATER
CTSO
CTSO
Cash + ST InvestmentsLiquidity on hand
$4.9M
$6.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$15.2M
$5.9M
Total Assets
$29.6M
$44.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATER
ATER
CTSO
CTSO
Q4 25
$4.9M
$6.2M
Q3 25
$7.6M
$7.5M
Q2 25
$10.5M
$10.2M
Q1 25
$14.3M
$11.6M
Q4 24
$18.0M
$3.3M
Q3 24
$16.1M
$5.7M
Q2 24
$20.3M
$8.5M
Q1 24
$17.5M
$8.6M
Total Debt
ATER
ATER
CTSO
CTSO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$13.8M
Q2 24
$13.7M
Q1 24
$4.4M
Stockholders' Equity
ATER
ATER
CTSO
CTSO
Q4 25
$15.2M
$5.9M
Q3 25
$22.6M
$9.0M
Q2 25
$24.3M
$11.6M
Q1 25
$27.0M
$14.5M
Q4 24
$30.0M
$11.1M
Q3 24
$30.6M
$13.4M
Q2 24
$30.9M
$17.4M
Q1 24
$33.0M
$19.6M
Total Assets
ATER
ATER
CTSO
CTSO
Q4 25
$29.6M
$44.2M
Q3 25
$40.1M
$45.8M
Q2 25
$45.4M
$48.0M
Q1 25
$49.8M
$50.8M
Q4 24
$49.5M
$47.4M
Q3 24
$52.1M
$47.8M
Q2 24
$59.9M
$53.4M
Q1 24
$55.7M
$47.1M
Debt / Equity
ATER
ATER
CTSO
CTSO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.03×
Q2 24
0.78×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATER
ATER
CTSO
CTSO
Operating Cash FlowLast quarter
$-1.0M
$-4.8M
Free Cash FlowOCF − Capex
$-1.0M
$-4.9M
FCF MarginFCF / Revenue
-6.9%
-53.4%
Capex IntensityCapex / Revenue
0.0%
1.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATER
ATER
CTSO
CTSO
Q4 25
$-1.0M
$-4.8M
Q3 25
$-1.6M
$-2.6M
Q2 25
$-4.4M
$-1.5M
Q1 25
$-3.9M
$-3.5M
Q4 24
$-9.0K
$-2.3M
Q3 24
$-722.0K
$-2.5M
Q2 24
$2.9M
$-4.8M
Q1 24
$-6.0K
$-4.8M
Free Cash Flow
ATER
ATER
CTSO
CTSO
Q4 25
$-1.0M
$-4.9M
Q3 25
$-1.6M
$-2.6M
Q2 25
$-4.4M
$-1.5M
Q1 25
$-3.5M
Q4 24
$-2.4M
Q3 24
$-2.6M
Q2 24
$2.9M
$-4.8M
Q1 24
$-42.0K
$-4.9M
FCF Margin
ATER
ATER
CTSO
CTSO
Q4 25
-6.9%
-53.4%
Q3 25
-8.4%
-27.3%
Q2 25
-22.7%
-16.1%
Q1 25
-39.7%
Q4 24
-26.3%
Q3 24
-30.4%
Q2 24
10.3%
-54.4%
Q1 24
-0.2%
-54.2%
Capex Intensity
ATER
ATER
CTSO
CTSO
Q4 25
0.0%
1.2%
Q3 25
0.2%
0.2%
Q2 25
0.0%
0.4%
Q1 25
0.0%
0.0%
Q4 24
0.0%
0.8%
Q3 24
0.0%
1.8%
Q2 24
0.0%
0.2%
Q1 24
0.2%
0.5%
Cash Conversion
ATER
ATER
CTSO
CTSO
Q4 25
Q3 25
Q2 25
-0.78×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATER
ATER

Sales Channel Directly To Consumer$13.1M87%
Heating Cooling And Air Quality$2.1M14%

CTSO
CTSO

Direct$5.1M55%
Distributors And Strategic Partners$4.2M45%

Related Comparisons